Abstract
It has been another active year of advances in our understanding and treatment of liver cancer. Here, we explore major research updates discovered throughout the year of 2024. Despite these significant advances, the treatment of patients with hepatocellular carcinoma (HCC) and Child-Pugh class C cirrhosis remains an unmet need.